1-3 of 3
Mubarak Al-Mansour, MD
Close
Sort by
Journal Articles

Interim Analysis Results from an International, Multi-Centre, Non-Interventional Retrospective Study to Describe Treatment Pathways, Outcomes, and Resource Use in Patients with Classical Hodgkin Lymphoma: B-CD30+ Hodgkin Lymphoma International Multi-Centre Retrospective Study of Treatment Practices and Outcomes (B-HOLISTIC)

Burhan Ferhanoglu, MD, Tae Min Kim, Gayane Tumyan, DMSc, MD PhD, Su-Peng Yeh, MD, David Brittain, MBBCh, FC Path, Cert Clin Haem, Amado Karduss, MD, Yok Lam Kwong, MD FRCP, Soon Thye Lim, MBBS, MRCP, FAMS, Mubarak Al Mansour, MD, Silvia Rivas-Vera, MD, Yuqin Song, MD PhD, Marta Zerga, MD, Julie Blair, PhD MD MPhil, Mehul Dalal, PhD, Hui Wan, MD PhD, Mark Hertzberg
Journal: Blood
Blood (2018) 132 (Supplement 1): 2917.
https://doi.org/10.1182/blood-2018-99-111146
Published: 2018
Journal Articles

The Outcome of Advanced Stage Nodular Lymphocyte Predominant Hodgkin's Lymphoma (NLPHL) Compared to Classical Hodgkin's Lymphoma (CHL): A Matched Pair Analysis

Katharine He Xing, MD, Joseph M. Connors, MD, Mubarak Al-Mansour, MD, Randy D. Gascoyne, MD, Brian Skinnider, MD, Kerry J. Savage, MD MSc
Journal: Blood
Blood (2012) 120 (21): 1531.
https://doi.org/10.1182/blood.V120.21.1531.1531
Published: 2012
Journal Articles

Incorporation of ABVD Increases Cure Rates of Patients with Limited Stage Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL)

Kerry Joanne Savage, MD, MSc, Brian Skinnider, MD, Mubarak Al Mansour, MD, Laurie H Sehn, MD, MPH, Randy D. Gascoyne, MD, Joseph M. Connors, MD
Journal: Blood
Blood (2010) 116 (21): 3887.
https://doi.org/10.1182/blood.V116.21.3887.3887
Published: 2010